New US monkeypox vaccine order prompts Bavarian Nordic upgrade
The US authorities have placed an order for an additional 2.5 million doses of Jynneos, the world’s only approved vaccine in the monkeypox indication.
by marketwire, translated by daniel pedersen
On Friday, the US Biomedical Advanced Research and Development Authority (BARDA) placed an order for an additional 2.5 million doses of Jynneos, reported Danish vaccine maker Bavarian Nordic in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
.jpg&w=384&q=75)
